Global Health And Vaccine Research program (GLOBVAC) has announced an overall budget of NOK 65 million during the 2018-2020 period. The call encourages research that sheds light on the transition from the MDGs to the SDGs. The deadline is February 14th 2018. The programme supports high quality research with potential for high impact that can contribute to sustainable improvements in health and health equity for people in low and lower-middle income countries. This programme /activity normally accepts grant applications from public and private Norwegian Research Institutions and Norwegian Companies.
Low- and lower-middle income countries are defined in accordance with the OECD DAC list that includes the following categories: least developed countries, other low-income countries, and lower middle-income countries and territories.
The objectives of the programme are to: Strengthen internationally competitive and sustainable research groups and institutions in Norway; Strengthen national and international research collaboration and partnerships; Strengthen capacity of research groups and institutions in LLMICs by supporting collaborative research and training, and Increase awareness of the need for global health research among policymakers, researchers and the general public.
The programme has a wide scope, but will give the highest priority to projects in the following thematic areas: Prevention and treatment of, and diagnostics for, communicable diseases, particularly vaccine and vaccination research; Family planning, reproductive, maternal, newborn, child and adolescent health;n Health systems and health policy research; Innovation in technology and methods development.
Research that cuts across two or more of the four thematic areas above is encouraged.
Implementation research is key to the effective deployment and scaling-up of efficacious health interventions. The programme may fund research and innovation along the whole R&D value chain as long as it is relevant for the primary objective of the programme. Multidisciplinary and interdisciplinary research approaches addressing the greatest global health challenges are particularly encouraged.
